2009
Label-free biomarker detection from whole blood
Abstract: Label-free nanosensors can detect disease markers to provide point-of-care diagnosis that is low-cost, rapid, specific and sensitive.1-13 However, detecting these biomarkers in physiological fluid samples is difficult because of problems like biofouling and nonspecific binding, and the resulting need to use purified buffers greatly reduces the clinical relevance of these sensors. Here, we overcome this limitation by using distinct components within the sensor to perform purification and detection. A microfluid…
Search citation statements
Paper Sections
Select...
442
101
12
10
Citation Types
1
344
0
2
Year Published
Range
2010
2026
Publication Types
Select...
452
52
36
9
Relationship
12
537
Authors
Journals
Cited by 548 publications
(347 citation statements)
References 30 publications
1
344
0
2
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The need for pervasive healthcare drives the field of in vitro diagnostics toward point-of-care solutions to detect biomolecules. − The technological requirements are very demanding, since point-of-care testing needs to be as reliable and quantitative as testing in a centralized laboratory and at the same time a faster response is required (in the order of a few minutes) in a cost-effective, portable, and integrated detection platform that operates on a small sample volume …”
supporting
confidence: 86%